Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · August 29, 2023

Outcomes of Using Icenticaftor, a CFTR Potentiator, in Patients With COPD

American Journal of Respiratory and Critical Care Medicine


Additional Info

American Journal of Respiratory and Critical Care Medicine
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial
Am J Respir Crit Care Med 2023 Aug 15;208(4)417-427, FJ Martinez, GJ Criner, C Gessner, M Jandl, F Scherbovsky, M Shinkai, TM Siler, CF Vogelmeier, R Voves, JA Wedzicha, C Bartels, I Bottoli, S Byiers, P Cardenas, JH Eckert, FS Gutzwiller, B Knorr, M Kothari, R Parlikar, AM Tanase, FME Franssen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading